Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna del Mazo-Barbara"'
Autor:
Clémentine Mirabel, Eduard Puente-Massaguer, Anna del Mazo-Barbara, Blanca Reyes, Philip Morton, Francesc Gòdia, Joaquim Vives
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background Successful delivery of cell-based therapeutics into patients is compromised by their short shelf-life upon release from production facilities due to the living nature of the active component that rapidly loses viability, and there
Externí odkaz:
https://doaj.org/article/f9bf04a209004b84af56e2d60ee04a45
Autor:
Marta Grau-Vorster, Luciano Rodríguez, Anna del Mazo-Barbara, Clémentine Mirabel, Margarita Blanco, Margarita Codinach, Susana G. Gómez, Sergi Querol, Joan García-López, Joaquim Vives
Publikováno v:
Cells, Vol 8, Iss 5, p 484 (2019)
Background: The selection of assays suitable for testing the potency of clinical grade multipotent mesenchymal stromal cell (MSC)-based products and its interpretation is a challenge for both developers and regulators. Here, we present a bioprocess d
Externí odkaz:
https://doaj.org/article/b8a151fb9d88457f9170cb4d75bea993
Autor:
Joaquim Vives, Anna del Mazo-Barbara, Joan García-López, Valentín Nieto, Clémentine Mirabel, Irene Oliver-Vila, Blanca Reyes
Publikováno v:
CYTOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Compliance with Good Manufacturing Practices (GMP) is mandatory in the development and manufacture of advanced therapy medicinal products, pushing academic developers to implement methods for control and monitoring of bioprocess parameters that, unti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a048d7cf976e3bfb99156e4c90deef
https://doi.org/10.1016/j.jcyt.2016.06.003
https://doi.org/10.1016/j.jcyt.2016.06.003
Autor:
Joan García-López, María Dolores López-Lucas, Marta Caminal, Margarita Codinach, Irene Oliver-Vila, Cesar G. Fontecha, Silvia Lope-Piedrafita, Joaquim Vives, Valentin Cabañas, Maria Isabel Coca, José M. Moraleda, Anna del Mazo-Barbara, Blanca Reyes
Publikováno v:
CYTOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Pompeu Fabra
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Pompeu Fabra
Background aims Biodistribution of candidate cell-based therapeutics is a critical safety concern that must be addressed in the preclinical development program. We aimed to design a decision tree based on a series of studies included in actual dossie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468dd755ba4a201bb2e654225eabc01b
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14135
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14135
